VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NIKI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NIKINiki BioSolutions, Inc.
$1.58$128670
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNIKIQuarterly Financials

Niki BioSolutions, Inc. (NIKI) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Niki BioSolutions, Inc. (NIKI) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

NIKI Income Statement

Quarterly statement

NIKI Income Statement

Niki BioSolutions, Inc. (NIKI) annual income statement — 9-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q4'24Q3'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q4'18Q2'18
Sales/Revenue0000000431.38K768.43K527.46K903.99K637.78K584.24K327.27K295.37K383.45K26.66K
Revenue Growth %------100%-100%-18.22%--54.73%94.88%97.8%--22.97%--
Cost of Goods Sold00000255.05K454.61K1.1M1.31M1.11M1.43M1.23M1.21M1.14M1.72M318.01K22.75K
COGS % of Revenue-------254.3%170.61%211.01%157.74%192.38%207.28%348.03%583.33%82.93%85.33%
Gross Profit00000-255K-455K-665K-542K-585K-522K-589K-627K-812K-1.43M65.44K3.91K
Gross Margin %--------154.16%-70.53%-110.91%-57.74%-92.35%-107.32%-248.11%-483.45%17.07%14.67%
Gross Profit Growth %--100%100%-61.65%16.05%-13.68%--16.75%27.46%56.09%--2282.15%--
Operating Expenses825.13K589.63K402.77K-558.6K692.39K2.47M3.54M5.87M8.52M7.87M9.19M8.9M10.98M7.48M8.56M10.39M4.88M
OpEx % of Revenue-------1361.68%1108.11%1491.29%1016.71%1396.24%1879.21%2284.94%2899.04%2710.65%18300.83%
Selling, General & Admin617.2K411.9K606.3K445.32K321.83K688.87K1.46M2.95M4.29M3.67M4.11M3.69M3.96M3.4M5.11M7.29M3.54M
SG&A % of Revenue-------684.32%558.93%695.78%454.65%577.94%677.29%1039.8%1730.35%1901.68%13263.32%
Research & Development91.71K241.79K19.38K-284.47K440.7K1.79M2.61M2.59M4.14M4.01M4.88M5.03M6.77M3.83M3.35M3.1M1.34M
R&D % of Revenue-------600.87%539.15%760.81%539.61%788.67%1159.46%1169.36%1134.83%808.71%5033.76%
Other Operating Expenses116.22K-64.07K-222.91K-719.46K-70.15K-6.87K-534K330K77.93K183K203K189K248K248K100K00
Operating Income00-402.77K0-692.39K-2.87M-3.99M-6.54M-9.06M-8.45M-9.71M-9.49M-11.61M-8.29M-9.99M-10.33M-4.88M
Operating Margin %--------1515.84%-1178.77%-1602.39%-1074.45%-1488.59%-1986.53%-2532.75%-3382.15%-2693.44%-18285.82%
Operating Income Growth %-100%85.96%100%-56.12%55.95%22.63%--16.31%-14.54%-16.18%-3.27%--
EBITDA-825.13K-589.63K-402.77K275.92K-687.8K-2.61M-3.54M-5.87M-8.43M-7.87M-9.12M-8.9M-10.97M-7.59M-8.69M-9.85M-4.67M
EBITDA Margin %--------1360.37%-1097.46%-1491.92%-1008.56%-1395.01%-1878.35%-2318.05%-2942.03%-2570.08%-17500.86%
EBITDA Growth %-399.04%14.27%84.59%107.8%-55.46%58.08%25.43%--16.92%-17.28%-26.28%-11.82%--
D&A (Non-Cash Add-back)00000255.05K454.61K670.65K624.8K582.71K595.71K596.86K632.03K702.63K1.3M473.02K209.27K
EBIT-825.13K-589.63K-402.77K275.92K-687.8K-2.59M2.29M-6.51M-8.79M-2.73M-10.01M-16.98M12.01M-6.84M-10.46M-19.94M-6.2M
Net Interest Income0-26.96K-46.53K0-40.71K-68.46K-27.67K-93.48K-3.15K149.73K32.5K-126.1K0-1.58M-3.7B00
Interest Income000000000149.73K32.5K000000
Interest Expense026.96K46.53K040.71K68.46K27.67K93.48K3.15K00126.1K-3.7B1.58M3.7B-4.81M-661K
Other Income/Expense-310.54K-616.6K-46.53K-770.35K-36.11K209.62K6.25M-65.94K262.28K5.72M-299K-7.61M23.51M1.3M-486K-4.81M-661K
Pretax Income-310.54K-616.6K-449.3K-770.35K-728.5K-2.66M2.26M-6.61M-8.79M-2.73M-10.01M-17.1M11.91M-6.99M-10.48M-15.13M-5.54M
Pretax Margin %--------1531.14%-1144.55%-517.57%-1107.53%-2681.47%2038.22%-2135.22%-3547.03%-3946.8%-20765.19%
Income Tax000000000000000-9.61M-1.32M
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%63.52%23.88%
Net Income-307.5K-614K-441.78K-919.9K-704.11K-2.64M2.66M-5.49M-7.91M-1.89M-8.97M-16.08M13.27M-6.21M-9.6M-14.83M-5.49M
Net Margin %--------1271.97%-1029.9%-357.37%-991.93%-2521.39%2271.51%-1895.97%-3249.44%-3868.04%-20585.15%
Net Income Growth %66.57%12.8%83.29%-134.56%-51.81%133.64%-191.09%---167.57%-159.16%238.27%-35.29%--
Net Income (Continuing)-310.54K-616.6K-449.3K-770.35K-728.5K-2.66M2.26M-6.61M-8.79M-2.73M-10.01M-17.1M11.91M-6.99M-10.48M-14.83M-5.49M
Discontinued Operations00000000000000000
Minority Interest-9.37M-9.37M-9.36M-9.36M--9.48M-9.46M-9.06M-7.88M-7M-6.1M-5.04M-3.68M-2.32M-1.51M-368.53K-113.34K
EPS (Diluted)-4.20-8.50-6.20-14.600.00-49.5051.00-142.50-221.60-52.80-25.20-46.9039.00-20.70-33.10-53.10-18.90
EPS Growth %71.23%-87.47%-128.63%-65.26%123.01%-169.89%---164.62%-126.57%217.82%-37.66%--
EPS (Basic)-4.20-8.50-6.20-14.600.00-49.5051.00-142.50-221.60-52.80-25.20-46.9039.00-20.70-33.10-53.10-18.90
Diluted Shares Outstanding73.52K72.39K71.27K62.9K053.4K51.82K38.5K35.71K35.68K356.4K342.8K340.2K299.6K290.4K279.1K290.15K
Basic Shares Outstanding73.52K72.39K71.27K62.9K053.4K51.82K38.5K35.71K35.68K356.4K342.8K340.2K299.6K290.4K279.1K290.15K
Dividend Payout Ratio------------5.69%----